Biomarker Testing in Lung Cancer - What Does It Mean?

Hossein Borghaei; Martin J. Edelman

doi:10.1001/jamanetworkopen.2020.7171

Biomarker Testing in Lung Cancer - What Does It Mean?

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	E207171
Journal	JAMA network open
Volume	3
Issue number	6
DOIs	https://doi.org/10.1001/jamanetworkopen.2020.7171
State	Published - Jun 8 2020

Keywords

Apoptosis
Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Humans
Lung Neoplasms/diagnosis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamanetworkopen.2020.7171

Cite this

@article{ddb1a2adea754b1a80262a6bcbf4d061,

title = "Biomarker Testing in Lung Cancer - What Does It Mean?",

keywords = "Apoptosis, Biomarkers, Tumor, Carcinoma, Non-Small-Cell Lung, Humans, Lung Neoplasms/diagnosis",

author = "Hossein Borghaei and Edelman, {Martin J.}",

year = "2020",

month = jun,

day = "8",

doi = "10.1001/jamanetworkopen.2020.7171",

language = "English",

volume = "3",

pages = "E207171",

journal = "JAMA network open",

issn = "2574-3805",